Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance

Abstract Everolimus, which inhibits mTOR kinase activity and is clinically used in graft rejection treatment, may have a two‐sided influence on metabolic syndrome; its role in obesity and hyperglycemic in animals and humans, however, has been explored insufficiently. This study further determined ho...

詳細記述

保存先:
書誌詳細
主要な著者: Geng‐Ruei Chang (著者), Po‐Hsun Hou (著者), Chao‐Min Wang (著者), Ching‐Feng Wu (著者), Huang‐Kai Su (著者), Huei‐Jyuan Liao (著者), To‐Pang Chen (著者)
フォーマット: 図書
出版事項: Wiley, 2021-04-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料